About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
Older
5 Mar 2018
Trading Halt
23 Feb 2018
Update accompanying Half Year Report
23 Feb 2018
Appendix 4D and Half Year Accounts
16 Feb 2018
NOX closes $4m capital raising for US subsidiary Nyrada Inc
31 Jan 2018
Appendix 4C - quarterly
25 Jan 2018
Section 708 Certificate
25 Jan 2018
Appendix 3B
18 Jan 2018
Section 708 Certificate
18 Jan 2018
Appendix 3B
17 Jan 2018
NOX receives FY17 R&D Tax Rebate
Previous
1
2
3
4
5
6
7
8
